Bivamelagon clinical trials

A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)

This study looks at a new medicine called Bivamelagon for people with a condition called Hypothalamic Obesity (HO). It's a long-term study, lasting up to two years, for those who have already tried Bivamelagon in an earlier study and found it safe and tolerable.